CN103127432A - Medicine capable of curing bronchitis - Google Patents
Medicine capable of curing bronchitis Download PDFInfo
- Publication number
- CN103127432A CN103127432A CN2013100538522A CN201310053852A CN103127432A CN 103127432 A CN103127432 A CN 103127432A CN 2013100538522 A CN2013100538522 A CN 2013100538522A CN 201310053852 A CN201310053852 A CN 201310053852A CN 103127432 A CN103127432 A CN 103127432A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- fructus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses medicine capable of curing bronchitis. The medicine capable of curing the bronchitis comprises the following components: 5 to 15 parts of platycodon qrandiflorus, 5 to 15 parts of dwarf lilythurf tuber, 5 to 15 parts of cortex mori radicis, 2 to 8 parts of houttuynia cordata, 2 to 8 parts of common hogfennel roots, 2 to 8 parts of fructus perillae and the like, wherein loquat cores, fritillaria cirrhosa, radix temonae, pear juice and the like are the main medicine. The medicine capable of curing the bronchitis is reasonable in component, components are supplementary to each other, the side effect is reduced, the curing effect is remarkable, the effects of cough relieving, phlegm reducing and inflammation diminishing can be achieved, the multiple symptoms of coughing, excessive phlegm and the like brought about by the bronchitis are eliminated, and the bronchitis is cured completely.
Description
Technical field
The present invention relates to the field of Chinese medicines, relate to specifically a kind of bronchitic medicine for the treatment of.
Background technology
Bronchitis is common with the old people, refers to the chronic nonspecific inflammation of trachea, bronchial mucosa and surrounding tissue thereof, clinically take cough, expectoration or with the chronic process of panting as feature.The general slow progress of the state of an illness, easily outbreak repeatedly, the Chang Jifa obstructive emphysema, even pulmonary hypertension, pulmonary heart disease, be a kind of commonly encountered diseases of serious harm people ' s health.The bronchitis Etiological is that the defense function of bronchial mucosa is low, and virus and the repeated infection of antibacterial have formed the chronic nonspecific inflammation of bronchial mucosa.When there's a sudden fall in temperature, degradation is beneficial to pathogenic under respiratory tract small blood vessel spasm ischemia, defense function, the chronic stimulations such as smog dust, atmosphere pollution also can be fallen ill, smoking makes bronchospasm, mucosa variation, ciliary movement reduction, mucous secretion increase favourable infection, and irritated factor also has certain relation.
The bronchitic medicine for the treatment of is a lot of at present, but curative effect is limited, and these medicines need long-term taking, in case stop using, the state of an illness will recur.But long-term taking can bring a lot of side effect.
Summary of the invention
The problem to be solved in the present invention is to provide a kind of good effect, instant effect and the bronchitic medicine of the treatment that has no side effect.
For addressing the above problem, the technical solution adopted in the present invention is:
A kind ofly treat bronchitic medicine, it is characterized in that, this medicine comprises following component:
Radix Platycodonis 5-15 part, Radix Ophiopogonis 5-15 part, Cortex Mori 5-15 part, Herba Houttuyniae 2-8 part, Radix Peucedani 2-8 part, Fructus Perillae 2-8 part, Radix Eriobotryae 5-15 part, Bulbus Fritillariae Cirrhosae 2-8 part, Flos Farfarae 10-20 part, Rhizoma Phragmitis 10-20 part, Pericarpium Citri Reticulatae 5-15 part, Radix Astragali 2-8 part, Poria 5-15 part, Russula juice 10-20 part, Radix Stemonae 10-20 part, Ganoderma 5-15 part, Semen Armeniacae Amarum 5-15 part, Corm Eleocharitis 5-15 part, crystal sugar 2-8 part, Radix Glycyrrhizae 5-15 part, Concha Meretricis seu Cyclinae 2-8 part, Herba Menthae 2-8 part, Rhizoma Pinelliae 2-8 part, Fructus Forsythiae 2-8 part, Sucus Pyri 10-20 part.
As a kind of improvement, this medicine comprises following component:
10 parts of Radix Platycodoniss, 10 parts of Radix Ophiopogonis, 10 parts of Cortex Mori, 5 parts of Herba Houttuyniae, 5 parts of Radix Peucedanis, 5 parts of Fructus Perillaes, 10 parts of Radix Eriobotryaes, 5 parts of Bulbus Fritillariae Cirrhosaes, 15 parts of Flos Farfaraees, 15 parts of Rhizoma Phragmitiss, 10 parts of Pericarpium Citri Reticulataes, 5 parts of the Radixs Astragali, 10 parts, Poria, 15 parts, Russula juice, 15 parts of the Radixs Stemonae, 10 parts of Ganodermas, 10 parts, Semen Armeniacae Amarum, 10 parts of Corm Eleocharitiss, 5 parts, crystal sugar, 10 parts, Radix Glycyrrhizae, 5 parts of Concha Meretricis seu Cyclinaes, 5 parts of Herba Menthaes, 5 parts of the Rhizoma Pinelliaes, 5 parts of Fructus Forsythiaes, 15 parts of Sucus Pyris.
Optionally, this medicine comprises following component:
15 parts of Radix Platycodoniss, 15 parts of Radix Ophiopogonis, 15 parts of Cortex Mori, 8 parts of Herba Houttuyniae, 8 parts of Radix Peucedanis, 8 parts of Fructus Perillaes, 15 parts of Radix Eriobotryaes, 8 parts of Bulbus Fritillariae Cirrhosaes, 20 parts of Flos Farfaraees, 20 parts of Rhizoma Phragmitiss, 15 parts of Pericarpium Citri Reticulataes, 8 parts of the Radixs Astragali, 15 parts, Poria, 20 parts, Russula juice, 20 parts of the Radixs Stemonae, 15 parts of Ganodermas, 15 parts, Semen Armeniacae Amarum, 15 parts of Corm Eleocharitiss, 8 parts, crystal sugar, 15 parts, Radix Glycyrrhizae, 8 parts of Concha Meretricis seu Cyclinaes, 8 parts of Herba Menthaes, 8 parts of the Rhizoma Pinelliaes, 8 parts of Fructus Forsythiaes, 20 parts of Sucus Pyris.
Optionally, this medicine comprises following component:
5 parts of Radix Platycodoniss, 5 parts of Radix Ophiopogonis, 5 parts of Cortex Mori, 2 parts of Herba Houttuyniae, 2 parts of Radix Peucedanis, 2 parts of Fructus Perillaes, 5 parts of Radix Eriobotryaes, 2 parts of Bulbus Fritillariae Cirrhosaes, 10 parts of Flos Farfaraees, 10 parts of Rhizoma Phragmitiss, 5 parts of Pericarpium Citri Reticulataes, 2 parts of the Radixs Astragali, 5 parts, Poria, 10 parts, Russula juice, 10 parts of the Radixs Stemonae, 5 parts of Ganodermas, 5 parts, Semen Armeniacae Amarum, 5 parts of Corm Eleocharitiss, 2 parts, crystal sugar, 5 parts, Radix Glycyrrhizae, 2 parts of Concha Meretricis seu Cyclinaes, 2 parts of Herba Menthaes, 2 parts of the Rhizoma Pinelliaes, 2 parts of Fructus Forsythiaes, 10 parts of Sucus Pyris.
Wherein:
Radix Platycodonis has lung qi dispersing and eliminates the phlegm, removing pus and relieving carbuncle, relieving cough and relieving asthma, the effect of clearing away heat from the throat and easing the chest.
Have promoting diuresis to eliminate damp pathogen Radix Ophiopogonis, spleen invigorating is reduced phlegm, the effect of mind tranquilizing and the heart calming.
Cortex Mori has eliminating pathogen from the lung for relieving asthma, the effect of inducing diuresis to remove edema.
But the Herba Houttuyniae heat-clearing and toxic substances removing, removing pus and relieving carbuncle, control that lung abscess vomiting pus, expectorant dyspnea of heat type are coughed, larynx Oh, hematodiarrhoea, carbuncle sore tumefacting virus, pyretic stranguria.
Radix Peucedani is controlled affection due to external wind and heat, the lung-heat phlegm stagnancy, and dyspnea and cough with excessive sputum, the expectorant Huang is sticky, and chest and diaphragm is full vexed.
The expectorant of Fructus Perillae sending down the abnormal ascending QI is relievingd asthma, anemofrigid cold, and expectorant is stopped up QI rising in reverse order, cough and asthma, cold expelling induces sweat.
The Radix Eriobotryae preventing phlegm from forming and stopping coughing, depressed liver-energy dispersing and QI regulating is effectively treated cough, cough with asthma, uncomfortable in chest, abundant expectoration that bronchitis causes, is one of important principal agent of the present invention.
Bulbus Fritillariae Cirrhosae has removing heat-phlegm, nourishing the lung to arrest cough, and the effect of mass dissipating and swelling eliminating is one of important principal agent of the present invention.
Flos Farfarae has nourishing the lung to keep the adverse QI downward, the effect of the antitussive that reduces phlegm.
The Rhizoma Phragmitis clearing away heat and promoting production of body fluid is used for the calentura excessive thirst, gastropyretic vomiting, cough due to lung-heat, lung abscess vomiting pus.
The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.
The Radix Astragali has invigorating QI to consolidate the body surface resistance, hidroschesis detoxification, granulation promoting, diuresis, the effect of detumescent.
Poria has promoting diuresis to eliminate damp pathogen, and spleen invigorating is reduced phlegm, the effect of mind tranquilizing and the heart calming.
Russula juice has that tonify deficiency nourishes blood, the effect of YIN nourishing, refreshing and detoxicating.
Radix Stemonae nourishing the lung to arrest cough is controlled pertussis, pulmonary tuberculosis, cough, bronchitis, and the pharmacological action of antibiotic, antitussive, alleviation bronchitis, smooth muscle spasm is arranged, and is one of important principal agent of the present invention.
Ganoderma property is controlled asthenia, cough, asthma, insomnia, dyspepsia, the diseases such as malignant tumor.
The Semen Armeniacae Amarum expelling phlegm for arresting cough is relievingd asthma, and exogenous cough, dyspnea with fullness of the chest, sore throat, the dry constipation of breast are controlled in intestine moistening.
Corm Eleocharitis has removing pathogenic heat from blood and toxic substance from the body, and the effect of eliminating the phlegm is controlled lung-dryness syndrome due to deficiency of YIN, phlegm-heat cough, discomfort in the throat.
The crystal sugar YIN nourishing and the production of body fluid promoting, nourishing the lung to arrest cough has good auxiliary therapeutic action to xeropulmonary cough, dry cough without phlegm, sputum with blood, controls the cough with asthma due to the dryness of the lung, the deficiency of the lung, wind and cold fatigue.
Radix Glycyrrhizae and middle emergency, lung moistening, detoxifcation is controlled the consumptive lung disease cough, the diseases such as laryngopharynx swelling and pain.
The Concha Meretricis seu Cyclinae heat clearing away, diuretic reduces phlegm, and softening the hard mass is controlled heat-phlegm and is breathed heavily and cough.
The Herba Menthae dispelling wind and heat pathogens, the clear sharp head, the sore-throat relieving rash, affection due to external wind and heat is controlled in soothing the liver circulation of qi promoting, laryngopharynx swelling and pain.
The Rhizoma Pinelliae has expectorant saliva, cough-relieving retroaction, energy strengthening the spleen and stomach, dissipating depression of QI eliminating stagnation, and the pharmacological action that obvious inhibition cough is arranged, eliminate the phlegm.
The Fructus Forsythiae heat-clearing and toxic substances removing, mass dissipating and swelling eliminating is controlled anemopyretic cold, and heating is vexed, laryngopharynx swelling and pain etc.
Sucus Pyri promotes the production of body fluid, moisturizes, heat clearing away, reduce phlegm, and is one of important principal agent of the present invention.
In the present invention, take Radix Eriobotryae, Bulbus Fritillariae Cirrhosae, the Radix Stemonae, Sucus Pyri, the Rhizoma Pinelliae as principal agent, other is auxiliary, complement each other, jointly reach cough-relieving, reduce phlegm, the effectiveness of antiinflammatory, can effectively eliminate the cough that bronchitis brings, many symptoms such as abundant expectoration are thoroughly eradicated bronchitis.
The specific embodiment
Embodiment 1: a kind ofly treat bronchitic medicine, this medicine comprises following component:
10 parts of Radix Platycodoniss, 10 parts of Radix Ophiopogonis, 10 parts of Cortex Mori, 5 parts of Herba Houttuyniae, 5 parts of Radix Peucedanis, 5 parts of Fructus Perillaes, 10 parts of Radix Eriobotryaes, 5 parts of Bulbus Fritillariae Cirrhosaes, 15 parts of Flos Farfaraees, 15 parts of Rhizoma Phragmitiss, 10 parts of Pericarpium Citri Reticulataes, 5 parts of the Radixs Astragali, 10 parts, Poria, 15 parts, Russula juice, 15 parts of the Radixs Stemonae, 10 parts of Ganodermas, 10 parts, Semen Armeniacae Amarum, 10 parts of Corm Eleocharitiss, 5 parts, crystal sugar, 10 parts, Radix Glycyrrhizae, 5 parts of Concha Meretricis seu Cyclinaes, 5 parts of Herba Menthaes, 5 parts of the Rhizoma Pinelliaes, 5 parts of Fructus Forsythiaes, 15 parts of Sucus Pyris.
Embodiment 2: a kind ofly treat bronchitic medicine, this medicine comprises following component:
15 parts of Radix Platycodoniss, 15 parts of Radix Ophiopogonis, 15 parts of Cortex Mori, 8 parts of Herba Houttuyniae, 8 parts of Radix Peucedanis, 8 parts of Fructus Perillaes, 15 parts of Radix Eriobotryaes, 8 parts of Bulbus Fritillariae Cirrhosaes, 20 parts of Flos Farfaraees, 20 parts of Rhizoma Phragmitiss, 15 parts of Pericarpium Citri Reticulataes, 8 parts of the Radixs Astragali, 15 parts, Poria, 20 parts, Russula juice, 20 parts of the Radixs Stemonae, 15 parts of Ganodermas, 15 parts, Semen Armeniacae Amarum, 15 parts of Corm Eleocharitiss, 8 parts, crystal sugar, 15 parts, Radix Glycyrrhizae, 8 parts of Concha Meretricis seu Cyclinaes, 8 parts of Herba Menthaes, 8 parts of the Rhizoma Pinelliaes, 8 parts of Fructus Forsythiaes, 20 parts of Sucus Pyris.
Embodiment 3: a kind ofly treat bronchitic medicine, this medicine comprises following component:
5 parts of Radix Platycodoniss, 5 parts of Radix Ophiopogonis, 5 parts of Cortex Mori, 2 parts of Herba Houttuyniae, 2 parts of Radix Peucedanis, 2 parts of Fructus Perillaes, 5 parts of Radix Eriobotryaes, 2 parts of Bulbus Fritillariae Cirrhosaes, 10 parts of Flos Farfaraees, 10 parts of Rhizoma Phragmitiss, 5 parts of Pericarpium Citri Reticulataes, 2 parts of the Radixs Astragali, 5 parts, Poria, 10 parts, Russula juice, 10 parts of the Radixs Stemonae, 5 parts of Ganodermas, 5 parts, Semen Armeniacae Amarum, 5 parts of Corm Eleocharitiss, 2 parts, crystal sugar, 5 parts, Radix Glycyrrhizae, 2 parts of Concha Meretricis seu Cyclinaes, 2 parts of Herba Menthaes, 2 parts of the Rhizoma Pinelliaes, 2 parts of Fructus Forsythiaes, 10 parts of Sucus Pyris.
In above-described embodiment, described " part " is 1 gram, and in embodiment, each component is made the step of decoct and is: selection by weight, soak 30 minutes, decoct 1 hour, filtering medicinal residues and obtain the medicinal liquid decoct.Instructions of taking is taken before sleep after supper for once-a-day, and five days is a course for the treatment of.
For further illustrating the property of medicine of medicine of the present invention, carry out respectively In Vitro Bacteriostasis experiment, and choose that white mice carries out cough-relieving, the experiment of reducing phlegm, to test white mice at every turn and be 50, male and female half and half are divided five groups at random, ten every group.Resulting experimental result is as follows:
(1) antibacterial
Adopt the In Vitro Bacteriostasis experimental technique to estimate this medicine to causing inhibition or the killing action of the antibacterial of respiratory tract infection in experiment.The experimental strain of this experiment is selected totally 100 strains of 5 kinds of antibacterials, comprises staphylococcus aureus, staphylococcus epidermidis, bacillus pyocyaneus, Klebsiella pneumoniae, each 20 strains of proteus vulgaris.Above bacterial strain is the clinical isolates strain.All strain all carries out the conventional method evaluation, and it is 1 * 10 that above-mentioned each bacterium is diluted to respectively concentration
5CFU/ml is standby.The Quality Control bacterial strain is staphylococcus aureus ATCC25922 and bacillus pyocyaneus ATCC27853, and it is 1 * 10 that the Quality Control bacterial strain is diluted to final concentration
5CFU/ml is standby.Adopt doubling dilution effective range antibacterial according to the prerun medicine that this medicine is diluted respectively with distilled water and be mixed with that final concentration is respectively 0.8352,1.272,2.98,6.9,13.7,30.1,57.9,121.3,234.1,473.3,931.7, the pastille agar plate culture medium of 1868.8g/ml, standby.Above operation is all carried out under aseptic condition.The bacterium liquid that dilution is good is inoculated into respectively the above-mentioned agar plate media surface that respectively contains the variable concentrations medicine with multiple spot inoculation instrument, the beta hemolytic streptococcus pastille BAP culture medium that contains 10% defiber Sanguis caprae seu ovis, cultivate 18h for 37 ℃, be the minimal inhibitory concentration (MIC) of this medicine without the least concentration of contained drug in the plate of bacterial growth.The results are shown in Table 1, in 5 kind of 100 strain clinical strains of testing, result shows, this medicine is stronger to the effect of staphylococcus aureus, staphylococcus epidermidis and klebsiella pneumoniae, illustrate that this medicine has inhibition or killing action preferably to the antibacterial that plays respiratory tract infection, proteus vulgaris and bacillus pyocyaneus also there are certain inhibitory action, but a little less than effect.As shown in Table 1, this medicine also has inhibitory action preferably to 2 strain Quality Control bacterial strains.
The impact of this medicine of table one on 5 kind of 102 strain antibacterial
(2) cough-relieving
By the strong aqua ammonia nebulization, estimate the antitussive action of this medicine.White mice is divided 5 groups, i.e. normal saline group, medicine matched group, respectively one group of this medicine embodiment 1, embodiment 2, embodiment 3, continuous gastric infusion 3d, medicine matched group adopt ZHENKELING 6.2ml/kg administration, after 3d administration 40min, white mice is put in the airtight glass container of 1000ml, spray into ammonia with ultrasound atomizer and excite the white mice cough, abdominal muscle occurs simultaneously with white mice and shrink, the contracting breast, open one's mouth, be the cough standard, record draws coughs white mice cough number of times in incubation period and 5min.The results are shown in Table two.This medicine embodiment 1, embodiment 2, embodiment 3 all can make the white mice cough latent period number of times that obviously extends, coughs obviously reduce, with blank group comparing difference, statistical significance is arranged all, and be certain dose-effect relationship, show that this medicine has antitussive action preferably.
This medicine of table two on white mice ammonia draw the impact coughed (
N=10)
(3) reduce phlegm
By observing this medicine to the white mice impact of phenol red output, estimate the resolve phlegm effect of this medicine.White mice is divided 5 groups, is respectively this medicine embodiment 1, embodiment 2, embodiment 3, and medicine matched group and blank group are disposable gastric infusion, and matched group is given and waited the capacity distilled water, and the medicine matched group adopts the ammonium chloride drug treatment.After administration 1h, give respectively the phenol red normal saline solution of mice by intraperitoneal injection 5%, the every 20g body weight of volume injected 0.5ml, after injecting phenol red 30min, white mice is put to death in the cervical vertebra dislocation, separates trachea, inserts syringe, connect to prick and fix, with 5% sodium bicarbonate lavation white mice trachea, bronchus, continuous 4 times, each 0.5ml, collect irrigating solution, measure absorbance with 722 type spectrophotometers at wavelength 546nm place, obtain the phenol red output of every white mice according to standard curve, between organizing relatively.The results are shown in Table three.This medicine embodiment 1, embodiment 2 and embodiment 3 all can make the phenol red output increase of white mice, with blank group comparing difference, statistical significance are arranged all, and are certain dose-effect relationship, illustrate that this medical instrument has phlegm-dispelling functions preferably.
This medicine of table three on the white mice impact of phenol red output (
N=10)
| Group | Phenol red concentration (mg/ml) |
| The blank group | 1.34±0.21 |
| Embodiment 1 | 2.79±0.54 |
| Embodiment 2 | 2.65±0.43 |
| Embodiment 3 | 2.54±0.46 |
| Ammonium chloride (1.0g/kg) | 2.96±0.61 |
Model case: in 100 routine patients through curing with this prescription, male 48 examples wherein, female's 52 examples are the course of disease the shortest half a year, the longest 12 years.
Efficacy determination: adopt recovery from illness, produce effects, effective, invalid 4 grade standards.
The therapeutic outcome statistics sees Table four
Table four
Effective percentage after one week for the treatment of of the present invention is 87%, and the effective percentage after the treatment surrounding is 99%.
Model case:
Feng, female, 25 years old, cotton mill, Weifang City workman, suffer with chronic bronchitis, because of the flu cough with asthma, uncomfortable in chest within the next few days, cough the sticking expectorant of yellow-white, take all sx↓s of this medicine one, situation uncomfortable in chest disappears substantially, and I feel that no longer the bronchitis symptom is arranged afterwards to take for two weeks, recovery from illness.
Zheng, the man, 35 years old, the Linqu County secondary school teachers, suffer from cold is that cough with asthma is felt suffocated throughout the year, takes all rear symptoms of this medicine one and substantially disappears, recovery from illness after two weeks is followed up a case by regular visits to 1 year nothing and is recurred.
Chen, the man, 43 years old, Qingzhou City Wang Fen town peasant occasionally had the symptoms such as cough, abundant expectoration, asthma, is diagnosed as bronchitis, took rear transference cure of one week of this medicine, added again a week because worrying, recovery from illness.
Huang, the female, 30 years old, the Qingzhou City company clerk, the low grade fever coughs yellow sticking expectorant more than 50 days, after transfer green thick sputum to, obstinate is taken all diseases of this medicine two and is fully recovered.
Claims (4)
1. treat bronchitic medicine for one kind, it is characterized in that: this medicine comprises following component:
Radix Platycodonis 5-15 part, Radix Ophiopogonis 5-15 part, Cortex Mori 5-15 part, Herba Houttuyniae 2-8 part, Radix Peucedani 2-8 part, Fructus Perillae 2-8 part, Radix Eriobotryae 5-15 part, Bulbus Fritillariae Cirrhosae 2-8 part, Flos Farfarae 10-20 part, Rhizoma Phragmitis 10-20 part, Pericarpium Citri Reticulatae 5-15 part, Radix Astragali 2-8 part, Poria 5-15 part, Russula juice 10-20 part, Radix Stemonae 10-20 part, Ganoderma 5-15 part, Semen Armeniacae Amarum 5-15 part, Corm Eleocharitis 5-15 part, crystal sugar 2-8 part, Radix Glycyrrhizae 5-15 part, Concha Meretricis seu Cyclinae 2-8 part, Herba Menthae 2-8 part, Rhizoma Pinelliae 2-8 part, Fructus Forsythiae 2-8 part, Sucus Pyri 10-20 part.
2. the bronchitic medicine for the treatment of according to claim 1, it is characterized in that: this medicine comprises following component:
10 parts of Radix Platycodoniss, 10 parts of Radix Ophiopogonis, 10 parts of Cortex Mori, 5 parts of Herba Houttuyniae, 5 parts of Radix Peucedanis, 5 parts of Fructus Perillaes, 10 parts of Radix Eriobotryaes, 5 parts of Bulbus Fritillariae Cirrhosaes, 15 parts of Flos Farfaraees, 15 parts of Rhizoma Phragmitiss, 10 parts of Pericarpium Citri Reticulataes, 5 parts of the Radixs Astragali, 10 parts, Poria, 15 parts, Russula juice, 15 parts of the Radixs Stemonae, 10 parts of Ganodermas, 10 parts, Semen Armeniacae Amarum, 10 parts of Corm Eleocharitiss, 5 parts, crystal sugar, 10 parts, Radix Glycyrrhizae, 5 parts of Concha Meretricis seu Cyclinaes, 5 parts of Herba Menthaes, 5 parts of the Rhizoma Pinelliaes, 5 parts of Fructus Forsythiaes, 15 parts of Sucus Pyris.
3. the bronchitic medicine for the treatment of according to claim 1, it is characterized in that: this medicine comprises following component:
15 parts of Radix Platycodoniss, 15 parts of Radix Ophiopogonis, 15 parts of Cortex Mori, 8 parts of Herba Houttuyniae, 8 parts of Radix Peucedanis, 8 parts of Fructus Perillaes, 15 parts of Radix Eriobotryaes, 8 parts of Bulbus Fritillariae Cirrhosaes, 20 parts of Flos Farfaraees, 20 parts of Rhizoma Phragmitiss, 15 parts of Pericarpium Citri Reticulataes, 8 parts of the Radixs Astragali, 15 parts, Poria, 20 parts, Russula juice, 20 parts of the Radixs Stemonae, 15 parts of Ganodermas, 15 parts, Semen Armeniacae Amarum, 15 parts of Corm Eleocharitiss, 8 parts, crystal sugar, 15 parts, Radix Glycyrrhizae, 8 parts of Concha Meretricis seu Cyclinaes, 8 parts of Herba Menthaes, 8 parts of the Rhizoma Pinelliaes, 8 parts of Fructus Forsythiaes, 20 parts of Sucus Pyris.
4. the bronchitic medicine for the treatment of according to claim 1, it is characterized in that: this medicine comprises following component:
5 parts of Radix Platycodoniss, 5 parts of Radix Ophiopogonis, 5 parts of Cortex Mori, 2 parts of Herba Houttuyniae, 2 parts of Radix Peucedanis, 2 parts of Fructus Perillaes, 5 parts of Radix Eriobotryaes, 2 parts of Bulbus Fritillariae Cirrhosaes, 10 parts of Flos Farfaraees, 10 parts of Rhizoma Phragmitiss, 5 parts of Pericarpium Citri Reticulataes, 2 parts of the Radixs Astragali, 5 parts, Poria, 10 parts, Russula juice, 10 parts of the Radixs Stemonae, 5 parts of Ganodermas, 5 parts, Semen Armeniacae Amarum, 5 parts of Corm Eleocharitiss, 2 parts, crystal sugar, 5 parts, Radix Glycyrrhizae, 2 parts of Concha Meretricis seu Cyclinaes, 2 parts of Herba Menthaes, 2 parts of the Rhizoma Pinelliaes, 2 parts of Fructus Forsythiaes, 10 parts of Sucus Pyris.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310053852.2A CN103127432B (en) | 2013-02-02 | 2013-02-02 | Medicine capable of curing bronchitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310053852.2A CN103127432B (en) | 2013-02-02 | 2013-02-02 | Medicine capable of curing bronchitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103127432A true CN103127432A (en) | 2013-06-05 |
| CN103127432B CN103127432B (en) | 2014-09-24 |
Family
ID=48488302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310053852.2A Expired - Fee Related CN103127432B (en) | 2013-02-02 | 2013-02-02 | Medicine capable of curing bronchitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103127432B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330828A (en) * | 2013-07-18 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | Traditional Chinese medicine snow pear lozenge and preparation method thereof |
| CN103637598A (en) * | 2013-11-15 | 2014-03-19 | 王芬 | Medical pillow for treating chronic bronchitis |
| CN105343720A (en) * | 2015-11-29 | 2016-02-24 | 韦富林 | Cortex lycii radicis composition medicine for treating bronchitis |
| CN105412299A (en) * | 2015-11-29 | 2016-03-23 | 韦富林 | Tetrapanax papyriferus combined medicine for treating acute mastitis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175440A (en) * | 1997-07-10 | 1998-03-11 | 迟经惠 | Pill for cough, asthma and lung carbuncle |
| CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
| CN101658631A (en) * | 2009-08-25 | 2010-03-03 | 路正平 | Drug for treating chronic bronchitis and pulmonary emphysema |
| CN102743737A (en) * | 2012-07-26 | 2012-10-24 | 吴伶 | Chinese medicinal preparation for effectively treating tracheitis |
-
2013
- 2013-02-02 CN CN201310053852.2A patent/CN103127432B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175440A (en) * | 1997-07-10 | 1998-03-11 | 迟经惠 | Pill for cough, asthma and lung carbuncle |
| CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
| CN101658631A (en) * | 2009-08-25 | 2010-03-03 | 路正平 | Drug for treating chronic bronchitis and pulmonary emphysema |
| CN102743737A (en) * | 2012-07-26 | 2012-10-24 | 吴伶 | Chinese medicinal preparation for effectively treating tracheitis |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330828A (en) * | 2013-07-18 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | Traditional Chinese medicine snow pear lozenge and preparation method thereof |
| CN103637598A (en) * | 2013-11-15 | 2014-03-19 | 王芬 | Medical pillow for treating chronic bronchitis |
| CN103637598B (en) * | 2013-11-15 | 2015-09-16 | 韩杰 | A kind of medicine-filled pillow for the treatment of chronic bronchitis |
| CN105343720A (en) * | 2015-11-29 | 2016-02-24 | 韦富林 | Cortex lycii radicis composition medicine for treating bronchitis |
| CN105412299A (en) * | 2015-11-29 | 2016-03-23 | 韦富林 | Tetrapanax papyriferus combined medicine for treating acute mastitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103127432B (en) | 2014-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657805B (en) | Loquat scented tea and preparation technology thereof | |
| CN102743737B (en) | Chinese medicinal preparation for effectively treating tracheitis | |
| CN100374149C (en) | Traditional Chinese medicine formulation for treating bronchitis and tonsillitis | |
| CN102416095B (en) | Chinese medicine composition for treating amygdalitis and pharyngitis | |
| CN103610788A (en) | Traditional Chinese medicine (TCM) for treating allergic rhinitis | |
| CN103127432B (en) | Medicine capable of curing bronchitis | |
| CN103110730A (en) | Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof | |
| CN105412749A (en) | Medicine for treating infantile pneumonia with dyspnea and cough and preparation method and application method thereof | |
| CN101721558B (en) | Cough stopping oral liquor for children | |
| CN103816281B (en) | A kind of Chinese medicine composition of prevention and treatment anemopyretic cold | |
| CN103169908A (en) | Cough and asthma relieving syrup and preparation method thereof | |
| CN103479932B (en) | One treats bronchitic Chinese medicine composition and preparation method thereof | |
| CN104547682A (en) | Composition with effects of clearing away lung heat, relieving sore throat, cooling throat and relieving asthma | |
| CN103142733A (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN106620205A (en) | Externally-used traditional Chinese medicine for foot bath to treat pediatric fever | |
| CN102198177A (en) | Formula of externally-applied Chinese medicine for treating nasosinusitis | |
| CN104524256A (en) | Traditional Chinese medicine for treating viral pneumonia | |
| CN104225180A (en) | Onion decoction for treating influenza and preparation method thereof | |
| CN103585451A (en) | Traditional Chinese medicine for treating children allergic rhinitis | |
| CN104474256A (en) | Oral liquor for treating acquired immunodeficiency syndrome lung infection | |
| CN103251925B (en) | Traditional Chinese medicine pill for treating diphtheria | |
| CN113304218B (en) | Traditional Chinese medicine for treating feline calicivirus infection | |
| CN103656326B (en) | One treats bronchitic medicine | |
| CN104189610A (en) | Traditional Chinese medicine composition for treating bronchitis | |
| CN105902910A (en) | Respiratory tract infection treating drop for pediatric nursing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: DAI YANG Free format text: FORMER OWNER: MENG XIANLAN Effective date: 20140702 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dai Yang Inventor after: Wang Ying Inventor after: Yi Yan Inventor before: Meng Xianlan Inventor before: Xu Meiling |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MENG XIANLAN XU MEILING TO: DAI YANG WANG YING YI YAN Free format text: CORRECT: ADDRESS; FROM: 262600 WEIFANG, SHANDONG PROVINCE TO: 262500 WEIFANG, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140702 Address after: 262500, No. 188, Wangfu West Street, Qingzhou, Shandong, Weifang Applicant after: Dai Yang Address before: The 262600 Shandong city of Weifang province Linqu County Road No. 21 Applicant before: Meng Xianlan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG YANYI COATING TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: DAI YANG Effective date: 20150106 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262500 WEIFANG, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150106 Address after: Shuangdian town of Rudong County in Jiangsu province 226400 Nantong double South neighborhood Patentee after: Nantong YanYi Coating Technology Co., Ltd. Address before: 262500, No. 188, Wangfu West Street, Qingzhou, Shandong, Weifang Patentee before: Dai Yang |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Shuangdian town of Rudong County in Jiangsu province 226400 Nantong double South neighborhood Patentee after: Nantong rock art wall Mstar Technology Ltd Address before: Shuangdian town of Rudong County in Jiangsu province 226400 Nantong double South neighborhood Patentee before: Nantong YanYi Coating Technology Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140924 Termination date: 20190202 |